Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Lilly presents novel RANKL-targeting fusion proteins

Sep. 7, 2017

VIB, Universiteit Ghent and Orionis Biosciences divulge PD-L1-targeting fusion proteins

Sep. 7, 2017

Novel phosphodiesterase PDE4B/A/C inhibitors identified at Pfizer

Sep. 7, 2017

Shanghai Institute Materia Medica discovers new AMP-activated protein kinase activators

Sep. 7, 2017

CSIR patents silicon-based cyclic antiparasitics

Sep. 7, 2017

Chrysalis presents new lysine-specific demethylase 5B inhibitors

Sep. 6, 2017

Novel antibacterial compounds identified at Redx Pharma

Sep. 6, 2017

U.S. Department of Health & Human Services creates new nucleic acids encoding arginase

Sep. 6, 2017

University of Primorska, Institute of Oncology Ljubljana patent IL-12 cancer gene therapy

Sep. 6, 2017

Farmar Licensing discloses novel recombinant beta2 glycoprotein 1 peptides

Sep. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...